CLARIVATE PLC Net Assets
CLARIVATE PLC net assets. Based on the latest financial reports, CLARIVATE PLC (CLVT) has net assets worth $4.79 Billion USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($10.93 Billion) and total liabilities ($6.14 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore CLVT net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.79 Billion |
| % of Total Assets | 43.82% |
| Annual Growth Rate | 25.29% |
| 5-Year Change | -59.39% |
| 10-Year Change | 1170.63% |
| Growth Volatility | 200.23 |
Net Assets of CLARIVATE PLC (2014–2025)
Net assets of CLARIVATE PLC from 2014 to 2025. This chart illustrates how CLARIVATE PLC's net assets have evolved over time, based on quarterly financial data. See CLARIVATE PLC (CLVT) net asset quality to measure how much of total assets are equity-financed.
Annual Net Assets for CLARIVATE PLC (2014–2025)
The table below shows the annual net assets of CLARIVATE PLC from 2014 to 2025. For live market cap and overall valuation, see market value of CLARIVATE PLC.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $4.84 Billion | -5.76% |
| 2024-12-31 | $5.14 Billion | -14.24% |
| 2023-12-31 | $5.99 Billion | -12.04% |
| 2022-12-31 | $6.81 Billion | -42.88% |
| 2021-12-31 | $11.93 Billion | +24.31% |
| 2020-12-31 | $9.59 Billion | +668.38% |
| 2019-12-31 | $1.25 Billion | +18.85% |
| 2018-12-31 | $1.05 Billion | -18.31% |
| 2017-12-31 | $1.29 Billion | +237.43% |
| 2016-12-31 | $381.14 Million | -3.26% |
| 2015-12-31 | $393.99 Million | -2.83% |
| 2014-12-31 | $405.47 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to CLARIVATE PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2155.4% over the analyzed period, potentially due to dividend distributions or operating losses.
CLARIVATE PLC Net Assets Breakdown (December 2025)
CLARIVATE PLC net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $12.81 Billion | 264.52% |
| Other Comprehensive Income | $-453.10 Million | -9.36% |
| Total Equity | $4.84 Billion | 100.00% |
CLARIVATE PLC Competitors by Market Cap
The table below lists competitors of CLARIVATE PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Test Research Inc
TW:3030
|
$1.50 Billion |
|
Investment and Industrial Development Joint Stock Corp
VN:BCM
|
$1.50 Billion |
|
Jungfraubahn Holding AG
SW:JFN
|
$1.50 Billion |
|
Immunocore Holdings Ltd
NASDAQ:IMCR
|
$1.50 Billion |
|
Hainan Drinda Automotive Trim Co Ltd
SHE:002865
|
$1.50 Billion |
|
Oil Refineries Ltd.
TA:ORL
|
$1.50 Billion |
|
Guangdong Taienkang Pharmaceutical Co. Ltd
SHE:301263
|
$1.50 Billion |
|
Kimbell Royalty Partners LP
NYSE:KRP
|
$1.49 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CLARIVATE PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,139,000,000 to 4,842,900,000, a change of -296,100,000 (-5.8%).
- Net loss of 201,100,000 reduced equity.
- Share repurchases of 224,500,000 reduced equity.
- Other comprehensive income increased equity by 73,200,000.
- Other factors increased equity by 56,300,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-201.10 Million | -4.15% |
| Share Repurchases | $224.50 Million | -4.64% |
| Other Comprehensive Income | $73.20 Million | +1.51% |
| Other Changes | $56.30 Million | +1.16% |
| Total Change | $- | -5.76% |
Book Value vs Market Value Analysis
This analysis compares CLARIVATE PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.33x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.33x to 0.33x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $1.76 | $2.34 | x |
| 2017-12-31 | $4.21 | $2.34 | x |
| 2018-12-31 | $3.44 | $2.34 | x |
| 2019-12-31 | $4.56 | $2.34 | x |
| 2020-12-31 | $35.03 | $2.34 | x |
| 2021-12-31 | $18.61 | $2.34 | x |
| 2022-12-31 | $10.04 | $2.34 | x |
| 2023-12-31 | $8.92 | $2.34 | x |
| 2024-12-31 | $7.41 | $2.34 | x |
| 2025-12-31 | $7.19 | $2.34 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CLARIVATE PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -4.15%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -8.19%
- • Asset Turnover: 0.22x
- • Equity Multiplier: 2.29x
- Recent ROE (-4.15%) is above the historical average (-10.89%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 12.18% | 8.89% | 0.89x | 1.53x | $8.82 Million |
| 2015 | 11.03% | 8.12% | 0.81x | 1.67x | $4.06 Million |
| 2016 | 3.62% | 2.68% | 0.66x | 2.03x | $-24.32 Million |
| 2017 | -20.52% | -28.76% | 0.23x | 3.11x | $-392.54 Million |
| 2018 | -23.05% | -25.00% | 0.26x | 3.53x | $-347.22 Million |
| 2019 | -20.71% | -26.54% | 0.26x | 3.04x | $-383.49 Million |
| 2020 | -1.11% | -8.48% | 0.08x | 1.58x | $-1.07 Billion |
| 2021 | -2.27% | -14.41% | 0.09x | 1.69x | $-1.46 Billion |
| 2022 | -58.13% | -148.89% | 0.19x | 2.05x | $-4.64 Billion |
| 2023 | -15.21% | -34.66% | 0.21x | 2.12x | $-1.51 Billion |
| 2024 | -12.39% | -24.90% | 0.22x | 2.24x | $-1.15 Billion |
| 2025 | -4.15% | -8.19% | 0.22x | 2.29x | $-685.39 Million |
Industry Comparison
This section compares CLARIVATE PLC's net assets metrics with peer companies in the Information Technology Services industry.
Industry Context
- Industry: Information Technology Services
- Average net assets among peers: $590,098,010
- Average return on equity (ROE) among peers: 6.01%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CLARIVATE PLC (CLVT) | $4.79 Billion | 12.18% | 1.28x | $1.50 Billion |
| Accenture plc (ACN) | $1.76 Billion | 28.38% | 2.68x | $107.58 Billion |
| AIOS Tech Inc. (AIOS) | $189.80 Million | 9.28% | 0.49x | $28.01 Million |
| Alithya Group Inc (ALYAF) | $175.20 Million | 0.74% | 1.38x | $75.13 Million |
| Applied Digital Corporation (APLD) | $8.41 Million | -16.78% | 0.09x | $4.44 Billion |
| ARB IOT Group Limited Ordinary Shares (ARBB) | $294.49 Million | 24.92% | 0.12x | $6.06 Million |
| ASGN Inc (ASGN) | $634.41 Million | 12.17% | 1.01x | $897.55 Million |
| Aurora Innovation Inc (AUR) | $1.99 Billion | -40.10% | 0.13x | $7.24 Billion |
| BigBearai Holdings Inc (BBAI) | $100.40 Million | -2.54% | 1.18x | $1.06 Billion |
| Broadridge Financial Solutions Inc (BR) | $745.80 Million | 25.77% | 2.80x | $18.21 Billion |
| BIT Mining Limited (BTCM) | $11.83 Million | 18.23% | 3.54x | $18.91 Million |
About CLARIVATE PLC
Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinar… Read more